
Acorda Therapeutics ACOR
Acorda Therapeutics ROA | ACOR
ROA Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -232.99 | -16.66 | -22.82 | -15.74 | -34.13 | 0.74 | -18.64 | -2.58 | 1.0 | 1.66 | 2.71 | 27.41 | 8.06 | -3.44 | -26.27 | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 27.41 | -232.99 | -22.11 |
ROA Vierteljährlich Acorda Therapeutics
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.07 | -13.01 | -22.07 | -25.28 | -20.79 | -26.6 | -27.73 | -21.97 | -16.19 | -15.15 | -11.74 | -7.94 | -2.22 | 5.99 | -24.99 | -24.89 | -27.89 | -35.37 | -6.48 | -0.49 | 2.68 | -12.34 | -13.15 | -17.46 | -18.2 | -4.15 | -3.24 | -3.99 | -2.6 | -1.54 | -0.21 | 1.23 | 1.0 | 0.2 | 1.07 | 1.48 | 1.87 | 2.86 | 2.91 | 3.09 | 2.77 | 25.27 | 26.34 | 26.78 | 29.02 | 8.84 | 11.88 | 10.67 | 8.43 | 8.84 | 1.18 | -0.2 | 3.75 | -2.28 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 29.02 | -43.07 | -4.91 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Annexon
ANNX
|
-74.47 | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
-11.69 | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
9.42 | - | - | $ 1.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-5.16 | - | -4.36 % | $ 27 M | ||
|
Avenue Therapeutics
ATXI
|
-99.25 | - | -52.27 % | $ 4.45 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-55.34 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Achieve Life Sciences
ACHV
|
-130.77 | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
3.06 | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
-83.75 | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
-46.76 | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
-428.94 | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
-77.77 | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
-49.24 | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
-39.61 | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
-249.92 | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
-23.1 | - | -23.04 % | $ 26.6 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Verona Pharma plc
VRNA
|
-36.57 | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
1.33 | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
4.27 | - | - | $ 109 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
-63.89 | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
-57.64 | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
-55.55 | - | - | $ 591 K | ||
|
Virpax Pharmaceuticals
VRPX
|
-775.72 | - | -45.12 % | $ 2.85 M | ||
|
Navidea Biopharmaceuticals
NAVB
|
-347.18 | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-104.58 | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-156.23 | - | 31.87 % | $ 1.61 M | ||
|
BioDelivery Sciences International
BDSI
|
26.14 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
-52.3 | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
-57.66 | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
-42.62 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
-315.07 | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
-49.91 | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
-55.07 | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
-84.31 | - | - | $ 127 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-41.31 | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
14.42 | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
-2.38 | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
2.77 | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
-23.57 | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
-3565.14 | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
-72.91 | - | - | $ 58.1 M |